Dr. Schachter specializes in ocular surface disease and serves as a Vision Source administrator for central California coast. He serves on the advisory board for Allergan, BlephEx, Sun Pharma, and ScienceBased Health, and he is a speaker for Allergan, Bau
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.
Scott Schacter, OD, discusses how he incorporates intense pulsed light (IPL) as a treatment for patients in his practice.